Interesting, and good, they are literally working with the country to help the nation itself while advancing the lives of the citizens, taking care of the resources there along with the company itself too ... this explains the conference call the other day when they indicated working WITH the government... read about Nagoya protocol [{“In 2008, a research authorization was granted for the study of the venom of Rhopalurus princeps, the Caribbean blue scorpion, for possible pharmaceutical application. In 2017, the Dominican-based company Medolife announced that the drug had been approved for cancer treatments.”}]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.